Drug survival of second biological DMARD therapy in patients with rheumatoid arthritis: a retrospective non-interventional cohort analysis
Crossref DOI link: https://doi.org/10.1186/s12891-017-1684-0
Published Online: 2017-08-02
Published Print: 2017-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Wilke, Thomas
Mueller, Sabrina
Lee, Sze Chim
Majer, Istvan
Heisen, Marieke
Funding for this research was provided by:
Bristol Myers Squibb (US)